Chuan-huizi Chen
Kunming, 650500, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Design and synthesis of quinazoline derivatives as novel JMJD3/HDAC dual-target inhibitors.
Journal: RSC medicinal chemistry
Published: May 27, 2026
In vitro identification of oridonin hybrids as potential anti-TNBC agents inducing cell cycle arrest and apoptosis by regulation of p21, γH2AX and cleaved PARP.
Journal: RSC medicinal chemistry
Published: July 26, 2024
A silicon-containing aryl/penta-1,4-dien-3-one/amine hybrid exhibits antiproliferative effects on breast cancer cells by targeting the HSP90 C-terminus without inducing heat-shock response.
Journal: RSC medicinal chemistry
Published: August 23, 2023
Development of actein derivatives as potent anti-triple negative breast cancer agents.
Journal: Bioorganic & medicinal chemistry letters
Published: February 15, 2023
Design, synthesis, and anti-triple negative breast cancer activity of novel Toosendanin derivatives.
Design, synthesis, and anti-triple negative breast cancer activity of novel Toosendanin derivatives.
Journal: Bioorganic & medicinal chemistry letters
Published: December 06, 2022
A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancer.
Journal: Cancer letters
Published: December 22, 2021
YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer.
Journal: Cell death and differentiation
Published: June 06, 2021
KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1.
Journal: Cancer letters
Published: February 05, 2021
Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer.
Journal: Cell death and differentiation
Published: January 04, 2021
Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis.
Journal: International journal of biological sciences
Published: August 20, 2019
Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers.
Journal: International journal of biological sciences
Published: March 22, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026